Infinity Pharmaceuticals, Inc.

	INVESTORS/MEDIA HOME
	PRESS RELEASES
	NEWS ARTICLES
	EVENTS & PRESENTATIONS
	CORPORATE GOVERNANCE
	FINANCIAL INFORMATION
	SEC Filings Annual Reports Quarterly Results
	STOCK INFORMATION
	SCIENTIFIC PUBLICATIONS
	CONTACT US

Stock Information

NASDAQ:INFI
$5.01 + 0.04

Sep 2, 2010
4:00 PM ET

Quotes delayed at least 20 minutes. Data provided by eSignal.

Quarterly Results

Second Quarter 2010

SEC Filing
	Form 10-Q
News Release
	Infinity Announces Second Quarter 2010 Results Conference Call
Calendar Event
	Infinity Pharmaceuticals Second Quarter 2010 Results

First Quarter 2010

SEC Filing
	Form 10-Q
News Release
	Infinity Reports R&D Highlights and Announces First Quarter 2010 Financial Results
Calendar Event
	Infinity Pharmaceuticals First Quarter 2010 Results

Fourth Quarter 2009

SEC Filing
	Form 10-K
News Release
	Infinity Initiates Clinical Development of Its Fourth Drug Candidate and Announces 2009 Financial Results
Calendar Event
	Infinity Pharmaceuticals Fourth Quarter 2009 Results

Third Quarter 2009

SEC Filing
	Form 10-Q
News Release
	Infinity Announces Third Quarter 2009 Results Conference Call
Calendar Event
	Infinity Pharmaceuticals Third Quarter 2009 Results

Second Quarter 2009

SEC Filing
	Form 10-Q
News Release
	Infinity Reports Recent R&D Highlights and Second Quarter 2009 Results

First Quarter 2009

Fourth Quarter 2008

Third Quarter 2008

Second Quarter 2008

First Quarter 2008

News Release
	Infinity Announces Conference Call Discussing R&D Progress and First Quarter 2008 Results